Enhancer reprogramming promotes pancreatic cancer metastasis. 

Roe J.S., Hwang C.I., Somerville T.D.D., Milazzo J.P., Lee E.J., Da Silva B., Maiorino L., Tiriac H., Young C.M., Miyabayashi K., Filippini D., Creighton B., Burkhart R.A., Buscaglia J.M., Kim E.J., Grem J.L., Lazenby A.J., Grunkemeyer J.A., Hollingsworth M.A., Grandgenett P.M., Egeblad M., Park Y., Tuveson D.A., and Vakoc C.R. (2017) Enhancer reprogramming promotes pancreatic cancer metastasis. Cell, 170, 875-888.